Objective: Thoracic blunt aortic injuries (TBAIs) are the second most common cause of death due to blunt trauma in the United States. Patients with minimal injuries do not require surgical repair; patients with severe injuries are treated emergently. Moderate aortic injuries are repaired in a semielective fashion; the optimal management of moderate TBAI patients and associated intracranial hemorrhage (ICH) is unknown. We sought to analyze the management and outcomes of patients presenting with concomitant moderate TBAI and ICH.
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Methods: This was a single-center, retrospective study of all consecutive patients who received a thoracic endovascular aortic repair (TEVAR) at our institution for treatment of moderate TBAI between 2014 and 2017. TBAIs were classified as minimal, moderate, and severe. ICH was identified on computed tomography scan and its severity determined by a neurosurgical team. Outcome measures included surgical timing, technique, and surgical outcomes.
Results: There were 87 patients who presented with TBAI during the study period; 52 patients had a moderate TBAI and underwent TEVAR (mean age, 44 years; range, 16-88 years). There were 41 were male patients (79%), and 20 patients (38%) presented with ICH. Median time from admission to surgery was 58.5 hours for patients with ICH and 26.5 hours for non-ICH patients (Table) . Operations were performed when the neurosurgical service thought the ICH was stable. Heparin was administered intravenously in all patients without ICH and in 19 of 20 (95%) non-ICH patients. Protamine reversal was used in 80% of patients with ICH and 75% of non-ICH patients. No patient developed stroke or spinal cord injury. Worsening ICH was seen in only one patient. This patient underwent operation 97 hours after admission and was receiving an intravenous heparin infusion for pulmonary embolus 24 hours before TEVAR. There was no aorta-related mortality in either group. The 30-day mortality was 5% for ICH patients and 3% for non-ICH patients.
Conclusions: Moderate aortic injuries can be managed in a semielective fashion. TEVAR can safely be performed in patients with ICH once the patient's ICH has been deemed stable. Administration of heparin has no influence on outcomes with regard to worsening of ICH. Objective: Regional anesthesia-induced vasodilation increases the proportion of patients with venous anatomy suitable for an arteriovenous fistula (AVF). The functional outcomes of AVFs initially small for size on preoperative duplex ultrasound vein mapping (2.4 mm) that are recruited under regional anesthesia have not been clearly defined. We aimed to evaluate reintervention rates and functional outcomes of AVFs recruited after induction of regional anesthesia.
Methods: A prospectively maintained quality improvement database from a single institution was queried for patients who had dialysis access created under regional anesthesia. We compared AVFs created according to the original surgical plan (preoperative minimum vein diameter >2.5 mm) with AVFs recruited with regional anesthesia (RWR; preoperative minimum vein diameter of 2.4 mm). End points included complication rates, reintervention rates, and functional outcomes at 6 months.
Comparisons were performed using c 2 tests. Results: Between July 2014 and October 2017, there were 208 dialysis access cases performed under regional anesthesia. Excluding grafts, revisions, patients with previous ipsilateral AVFs, and those without preoperative ultrasound vein mapping, 135 patients were included in our analysis. Induction of regional anesthesia with intraoperative duplex ultrasound allowed a change in surgical plan in 55 of 135 (42%) patients (RWR), including 31 patients originally scheduled for an arteriovenous graft (mean preoperative distal upper arm cephalic vein diameter, 1.3 mm; standard deviation, 0.9 mm) who were converted to an AVF (12 brachiobasilic, 11 brachiocephalic, and 8 radiocephalic). The remainder of RWR AVFs included 13 patients scheduled for brachiobasilic who were converted to brachiocephalic or radiocephalic and 11 patients scheduled for brachiocephalic who were converted to radiocephalic. In comparing the original surgical plan with RWR, there were no differences in reintervention rates (30% vs 22%; P ¼ .33) or functional outcomes at 6 months (60% vs 65% used on hemodialysis [P ¼ .58] and 13% vs 9% failed [P ¼ .59]).
Conclusions: In this series, regional anesthesia increased the proportion of patients who underwent AVF creation without compromising functional outcomes. Routine use of regional anesthesia in access surgery could have significant implications in meeting national guidelines for autogenous access in the prevalent hemodialysis population. Objective: Peripheral arterial disease (PAD) is characterized by lowgrade systemic inflammation. Monocytes and monocyte-derived macrophages (MDMs) play a central role in vascular inflammation and its resolution. We hypothesize that impaired resolution in PAD contributes to adverse clinical outcomes.
Methods: In a cross-sectional study, we profiled serum cytokines, phagocytic activity of leukocytes, monocyte cell surface markers, and gene expression of MDM from healthy individuals (n $ 10) and patients with stable claudication (n $ 10). Leukocyte phagocytosis of fluorescently labeled Escherichia coli and monocyte surface markers were determined by flow cytometry. MDMs were cultured from peripheral blood monocytes isolated by density gradient centrifugation. MDM cytokine production and gene expression, before and after stimulation with lipopolysaccharide, were determined by enzyme-linked immunosorbent assay and quantitative polymerase chain reaction, respectively. 
